Suitability of date palm (Phoenix dactyliferia) branches for particleboard production

G. Nemli,H. Kalaycioğlu,T. Alp

DOI: https://doi.org/10.1007/s00107-001-0257-x

2001-12-01

Abstract:

What problem does this paper attempt to address?

Immune-Neurovascular Interactions in Experimental Perinatal and Childhood Arterial Ischemic Stroke

Carina Mallard,Donna M. Ferriero,Zinaida S. Vexler

DOI: https://doi.org/10.1161/strokeaha.123.043399

IF: 10.17

2024-01-23

Stroke

Abstract:Stroke, Volume 55, Issue 2, Page 506-518, February 1, 2024. Emerging clinical and preclinical data have demonstrated that the pathophysiology of arterial ischemic stroke in the adult, neonates, and children share similar mechanisms that regulate brain damage but also have distinct molecular signatures and involved cellular pathways due to the maturational stage of the central nervous system and the immune system at the time of the insult. In this review, we discuss similarities and differences identified thus far in rodent models of 2 different diseases—neonatal (perinatal) and childhood arterial ischemic stroke. In particular, we review acquired knowledge of the role of resident and peripheral immune populations in modulating outcomes in models of perinatal and childhood arterial ischemic stroke and the most recent and relevant findings in relation to the immune-neurovascular crosstalk, and how the influence of inflammatory mediators is dependent on specific brain maturation stages. Finally, we discuss the current state of treatments geared toward age-appropriate therapies that signal via the immune-neurovascular interaction and consider sex differences to achieve successful translation.

peripheral vascular disease,clinical neurology
Infection and Pediatric Arterial Ischemic Stroke Presumably Related to Focal Cerebral Arteriopathy: Data From the COVID-19 Pandemic

Raluca Tudorache,Manon Jaboyedoff,Amélie Gabet,Valérie Olié,François Angoulvant,Philippe Tuppin,Thomas Lesuffleur,Manoelle Kossorotoff

DOI: https://doi.org/10.1161/strokeaha.123.045632

IF: 10.17

2024-05-26

Stroke

Abstract:Stroke, Volume 55, Issue 6, Page 1672-1675, June 1, 2024. BACKGROUND:Infection may trigger pediatric arterial ischemic stroke (PAIS), notably when related to focal cerebral arteriopathy. Community- and individual-level nonpharmaceutical interventions during the COVID-19 pandemic resulted in a major decrease in pediatric viral infections. We explored the consequences on the incidence of PAIS.METHODS:Using national public health databases, we identified children hospitalized between 2015 and 2022 with PAIS. Using an age proxy (29 days to 7 years) and excluding patients with cardiac and hematologic conditions, we focused on children with PAIS presumably related to focal cerebral arteriopathy or with no definite cause. Considering the delay between infection and PAIS occurrence, we compared a prepandemic reference period, a period with nonpharmaceutical interventions, and a post-nonpharmaceutical intervention period.RESULTS:Interrupted time-series analyses of the monthly incidence of PAIS in this group showed a significant decrease in the nonpharmaceutical intervention period compared with the prepandemic period: −33.5% (95% CI, −55.2%, −1.3%);P=0.043.CONCLUSIONS:These data support the association between infection and PAIS presumably related to focal cerebral arteriopathy.

peripheral vascular disease,clinical neurology
Be aware of childhood stroke: Proceedings from EPNS Webinar

Gabriela Oesch,Robin Münger,Maja Steinlin

DOI: https://doi.org/10.1016/j.ejpn.2024.02.001

IF: 3.692

2024-02-25

European Journal of Paediatric Neurology

Abstract:Childhood arterial ischaemic stroke (AIS) is a significant health concern with increasing incidence. This review aims to provide an overview of the current understanding of childhood AIS. The incidence of childhood AIS is on the rise especially in developing countries, likely due to improved awareness and diagnostic capabilities. Aetiology of childhood AIS is multifactorial, with both modifiable risk factors and genetic predisposition playing important roles. Identifying and addressing these risk factors, such as infection, sickle cell disease, and congenital heart defects, is essential in prevention and management. Identifying underlying conditions through genetic testing is important for appropriate management and long-term prognosis. Clinically, distinguishing stroke from stroke mimics can be challenging. Awareness of important stroke mimics, including migraines, seizures, and metabolic disorders, is crucial to avoid misdiagnosis and ensure appropriate treatment. The diagnostic approach to childhood AIS involves a comprehensive "chain of care," including initial assessment, neuroimaging, and laboratory investigations. National guidelines play a pivotal role in standardizing and streamlining the diagnostic process, ensuring prompt and accurate management. Early intervention is critical in the management of childhood AIS. Due to the critical time window, the question if mechanical thrombectomy is feasible and beneficial should be addressed as fast as possible. Early initiation of antiplatelet therapy and, in select cases, thrombolysis can help restore blood flow and minimize long-term neurological damage. Additionally, rehabilitation should start as soon as possible to optimize recovery and improve functional outcomes. In conclusion, childhood AIS is a growing concern. Understanding the increasing incidence, age distribution, risk factors, clinical presentation, diagnostic approach, and management strategies is crucial for optimized management of these patients.

pediatrics,clinical neurology
Abstract 112: Assessing the Impact of the COVID-19 Pandemic on Childhood Arterial Ischemic Stroke: An Unanticipated Natural Experiment

Heather J Fullerton,Clara Di Germanio,Nancy K Hills,Lauren A Beslow,Dana D Cummings,Nomazulu Dlamini,Christine K Fox,Lisa R Sun,Philip Norris,

DOI: https://doi.org/10.1161/str.55.suppl_1.112

IF: 10.17

2024-02-01

Stroke

Abstract:Introduction: The Vascular effects of Infection in Pediatric Stroke (VIPS II) study aimed to confirm prior findings that viral infection can trigger childhood arterial ischemic stroke (AIS). The COVID-19 pandemic developed midway through VIPS II enrollment, creating an opportunity to assess its impact. Methods: At 22 North American sites, we enrolled 205 children (28 days-18 years) with AIS (12/2016 - 1/2022), collected serum samples up to 7 days post-stroke, and measured clinical infection via parental interview. We defined the COVID-19 pandemic epoch as 1/2020-1/2022. We collected serum samples on 40 stroke-free controls (median [IQR] age 13.2 years [6.4, 16.5]) during the pandemic. We measured SARS-CoV2 spike IgG antibodies (present after vaccination or infection) and nucleocapsid IgG total antibodies (present after infection only; elevated for months). Results: The sites saw 117 AIS cases in 2019 (51 enrolled), 122 (44) in 2020, and 109 (52) in 2021. Comparing the pre-pandemic (N=105) and pandemic (N=100) cohorts, pandemic cases were less likely to report a recent infection (Table). Evidence of SARS-CoV2 infection was seen in 4 (10%) of controls and 26 (25%) of 100 pandemic cases (p=0.065); 10 of the 26 COVID positive cases reported a recent infection, and 7 of the 10 had a clinical diagnosis of COVID. Median (IQR) nucleocapsid IgG titers were 18.8 (12.0, 101) in the positive controls and 50.1 (26.9, 95.3) in the positive cases (p=0.33). Conclusions: The COVID19 pandemic reduced the proportion of childhood AIS cases with preceding infection, likely reflecting decreased infectious exposures while “stay at home” and masking policies were in effect. A quarter of cases in the pandemic era had positive antibodies consistent with prior SARS-CoV2 infection. Like other childhood respiratory viruses, SARS-CoV2 may act as a trigger for childhood AIS, but further investigation is needed to establish a causal role.

peripheral vascular disease,clinical neurology
Osteodystrophic diseases of sheep. II. Rickets in young sheep.

D. I. Nisbet,E. J. Butler,B. S. Smith,J. M. Robertson,C. Bannatyne

DOI: https://doi.org/10.1016/0021-9975(66)90018-1

IF: 1.083

1966-04-01

Journal of Comparative Pathology

Abstract:
Energetic aspects of CO2 uptake in Thiobacillus neapolitanus

Y. A. Holthuijzen,F.M.F. Van Dissel Emiliani,J. Kuenen,Wn Konings

DOI: https://doi.org/10.1007/BF00463489

IF: 2.667

Archives of Microbiology

Abstract:
Inflammation and Infections as Risk Factors for Ischemic Stroke

Perttu J. Lindsberg,Armin J. Grau

DOI: https://doi.org/10.1161/01.str.0000089015.51603.cc

IF: 10.17

2003-10-01

Stroke

Abstract:Background— Inflammatory processes have fundamental roles in stroke in both the etiology of ischemic cerebrovascular disease and the pathophysiology of cerebral ischemia. We summarize clinical data on infection and inflammation as risk or trigger factors for human stroke and investigate current evidence for the hypothesis of a functional interrelation between traditional risk factors, genetic predisposition, and infection/inflammation in stroke pathogenesis. Summary of Review— Several traditional vascular risk factors are associated with proinflammatory alterations, including leukocyte activation, and predispose cerebral vasculature to thrombogenesis on inflammatory stimulation. Furthermore, accumulation of inflammatory cells, mainly monocytes/macrophages, within the vascular wall starts early during atherogenesis. During later disease stages, their activation can lead to plaque rupture and thrombus formation, increasing stroke risk. Inflammatory markers (eg, leukocytes, fibrinogen, C-reactive protein) are independent predictors of ischemic stroke. Chronic infections (eg, infection with Chlamydia pneumoniae or Helicobacter pylori ) were found to increase the risk of stroke; however, study results are at variance, residual confounding is not excluded, and causality is not established at present. In case-control studies, acute infection within the preceding week was a trigger factor for ischemic stroke. Acute and exacerbating chronic infection may act by activating coagulation and chronic infections and may contribute to atherogenesis. Genetic predisposition of the inflammatory host response may be an important codeterminant for atherogenesis and stroke risk. Conclusions— Inflammation contributes to stroke risk via various interrelated mechanisms. Infectious diseases, traditional risk factors, and genetic susceptibility may cooperate in stimulating inflammatory pathways. Final proof of a causal role of infectious/inflammatory mechanisms in stroke pathogenesis is still lacking and will require interventional studies.

peripheral vascular disease,clinical neurology
New Directions in Infection-Associated Ischemic Stroke

Jin-Man Jung,András Gruber,Peter Heseltine,Kumar Rajamani,Sebastián F. Ameriso,Mark J. Fisher

DOI: https://doi.org/10.3988/jcn.2023.0056

2024-01-01

Journal of Clinical Neurology

Abstract:The relationship between infections and stroke has not been fully characterized, probably delaying the development of specific treatments. This narrative review addresses mechanisms of stroke linked to infections, including hypercoagulability, endothelial dysfunction, vasculitis, and impaired thrombolysis. SARS-CoV-2, the virus that causes COVID-19, may promote the development of stroke, which may represent its most severe neurological complication. The development of specific therapies for infection-associated stroke remains a profound challenge. Perhaps the most important remaining issue is the distinction between infections that trigger a stroke versus infections that are truly incidental. This distinction likely requires the establishment of appropriate biomarkers, candidates of which are elevated levels of fibrin D-dimer and anticardiolipin/antiphospholipid antibodies. These candidate biomarkers might have potential use in identifying pathogenic infections preceding stroke, which is a precursor to establishing specific therapies for this syndrome.

clinical neurology
The incidence of pediatric ischemic stroke: A systematic review and meta-analysis

Lan Gao,Megumi Lim,Dieu Nguyen,Steven Bowe,Belinda Stojanovski,Marj Moodie,Mark MacKay

DOI: https://doi.org/10.1177/17474930231155336

2023-02-09

International Journal of Stroke

Abstract:International Journal of Stroke, Ahead of Print. Background:Despite its importance in being among the top 10 causes of childhood death, there is limited data on the incidence of stroke in children and whether this has changed over time.Aims:We performed a systematic review and meta-analysis to estimate the worldwide incidence rate of pediatric ischemic stroke, identify population differences, and assess trends in incidence.Methods:We screened three databases (Medline, Embase, and Cumulative Index of Nursing and Allied Health Literature (CINAHL)) and a Google Search was performed up to October 2021. The protocol was pre-registered: PROSPERO: CRD42021273749. Data extraction and quality assessment were independently undertaken by two reviewers. A random-effects model was used for meta-analysis using Stata SE17 to calculate the overall incidence rate. Heterogeneity was assessed using I2. Meta-regression and assessment for bias were performed.Results:Out of 4166 records identified, 39 studies were included in the qualitative synthesis and the quantitative meta-analysis. The pooled incidence rate for all ischemic strokes varied from 0.9 to 7.9 per 100,000 person-years, with a pooled incidence of 2.09 (95% confidence interval (CI): 1.57–2.76). The pooled incidence was 1.28 (95% CI: 0.75–2.19) per 100,000 person-years for arterial ischemic stroke, and 0.56 (95% CI: 0.31–1.02) per 100,000 person-years for cerebral venous sinus thrombosis. The incidence of arterial ischemic stroke was high in neonates, less than 28 days old (18.51, 95% CI: 12.70–26.97). Significant heterogeneity was observed in the initial analyses of stroke incidence estimates, and geographical region, cohort age upper limit, length of study, study quality, and study design could not explain this. The incidence rate of childhood stroke appeared remained relatively stable over time.Conclusion:Our review provides estimates of global stroke incidence, including stroke subtypes, in children. It demonstrates a particularly high stroke incidence in neonates.

peripheral vascular disease,clinical neurology
Diffuse embryoma with intratubular germ‐cell neoplasia

M. Zamecnik,K. Sultani

DOI: https://doi.org/10.1111/j.1365-2559.2004.01943.x

2004-10-01

Histopathology

Abstract:another possibility—spindle epithelial tumour with thymus-like elements (SETTLE). On the other hand, the lack of significant atypia, mitotic activity, pleomorphism, necrosis, and invasiveness argue against a diagnosis of undifferentiated carcinoma. We think the present case is a metaplastic variant of PTC. Both neoplastic and normal thyroid follicular cells undergo a mesenchymal-like transition, with a fibroblastoid appearance and reactivity for keratin, thyroglobulin and vimentin when maintained in cell culture. In the present case, the lower intensity of immunoreactivity for keratins and thyroglobulin together with the strong expression of vimentin in the spindle cell component when compared with the follicular elements also support a mesenchymal-like metaplasia. Loss of E-cadherin is a common feature of poorly differentiated thyroid carcinoma but we think that in our case this reflects a lack of epithelial differentiation rather than dedifferentiation. As Carcangiu pointed out, there is no evidence that PTCs exhibiting spindle cell metaplasia behave differently than those lacking these features; consequently, it is important to recognize this variant of PTC as distinct from aggressive malignant neoplasms.
Immune Pathways in Etiology, Acute Phase, and Chronic Sequelae of Ischemic Stroke

Matthias Endres,Claudia Dames,Andreas Meisel,Maria A. Moro,Christian H. Nolte,Marion S. Buckwalter

DOI: https://doi.org/10.1161/CIRCRESAHA.121.319994

IF: 23.213

2022-04-16

Circulation Research

Abstract:Inflammation and immune mechanisms are crucially involved in the pathophysiology of the development, acute damage cascades, and chronic course after ischemic stroke. Atherosclerosis is an inflammatory disease, and, in addition to classical risk factors, maladaptive immune mechanisms lead to an increased risk of stroke. Accordingly, individuals with signs of inflammation or corresponding biomarkers have an increased risk of stroke. Anti-inflammatory drugs, such as IL (interleukin)-1β blockers, methotrexate, or colchicine, represent attractive treatment strategies to prevent vascular events and stroke. Lately, the COVID-19 pandemic shows a clear association between SARS-CoV2 infections and increased risk of cerebrovascular events. Furthermore, mechanisms of both innate and adaptive immune systems influence cerebral damage cascades after ischemic stroke. Neutrophils, monocytes, and microglia, as well as T and B lymphocytes each play complex interdependent roles that synergize to remove dead tissue but also can cause bystander injury to intact brain cells and generate maladaptive chronic inflammation. Chronic systemic inflammation and comorbid infections may unfavorably influence both outcome after stroke and recurrence risk for further stroke. In addition, stroke triggers specific immune depression, which in turn can promote infections. Recent research is now increasingly addressing the question of the extent to which immune mechanisms may influence long-term outcome after stroke and, in particular, cause specific complications such as poststroke dementia or even poststroke depression.

cardiac & cardiovascular systems,peripheral vascular disease,hematology
Factors Associated with Pathway-Concordant Neuroimaging for Pediatric Ischemic Stroke

Jillian K. Gorski,Divakar S. Mithal,Michele G. Mills,Sriram Ramgopal

DOI: https://doi.org/10.1016/j.jpeds.2024.113905

IF: 6.314

2024-01-07

The Journal of Pediatrics

Abstract:Objective To determine factors associated with magnetic resonance imaging (MRI) and non-invasive diagnostic angiography among children presenting to the emergency department (ED) with acute ischemic stroke. Study Design We performed a cross-sectional study using data from >50 US children's hospitals. We included children 29 days through 17 years old hospitalized from the ED with an International Classification of Disease, 10 th revision, diagnosis code for acute ischemic stroke between October 1, 2015, and November 30, 2022. We excluded children with a principal diagnosis code of trauma/external injury, without neuroimaging on day of presentation, and into-ED transfers. Our outcomes were defined as acquisition of MRI (versus computed tomography only) and angiography (versus no angiography) on day of presentation. We performed generalized linear mixed modeling with hospital as a random effect to determine the association of demographics, known comorbidities, and treatment factors with each outcome. Results We included 1,601 children. In multivariable analysis, younger age, mechanical ventilation, and Black race were associated with lower odds of MRI acquisition, while history of moyamoya disease and sickle cell disease were associated with higher odds. Younger age, mechanical ventilation, Hispanic ethnicity, Black race, other races, history of metabolic disease, and history of seizures were associated with lower odds of angiography. Conclusions Younger and non-White children experienced lower odds of MRI and angiography, which may be driven by health system limitations or provider implicit biases or both. Our results expose risk factors for underdiagnosis of ischemic stroke and provide opportunities to tailor institutional pathways reflective of underlying pathophysiology.

pediatrics
Neuroinflammation in Acute Ischemic and Hemorrhagic Stroke

Diana L Alsbrook,Mario Di Napoli,Kunal Bhatia,José Biller,Sasan Andalib,Archana Hinduja,Roysten Rodrigues,Miguel Rodriguez,Sara Y Sabbagh,Magdy Selim,Maryam Hosseini Farahabadi,Alibay Jafarli,Afshin A Divani

DOI: https://doi.org/10.1007/s11910-023-01282-2

Abstract:Purpose of review: This review aims to provide an overview of neuroinflammation in ischemic and hemorrhagic stroke, including recent findings on the mechanisms and cellular players involved in the inflammatory response to brain injury. Recent findings: Neuroinflammation is a crucial process following acute ischemic stroke (AIS) and hemorrhagic stroke (HS). In AIS, neuroinflammation is initiated within minutes of the ischemia onset and continues for several days. In HS, neuroinflammation is initiated by blood byproducts in the subarachnoid space and/or brain parenchyma. In both cases, neuroinflammation is characterized by the activation of resident immune cells, such as microglia and astrocytes, and infiltration of peripheral immune cells, leading to the release of pro-inflammatory cytokines, chemokines, and reactive oxygen species. These inflammatory mediators contribute to blood-brain barrier disruption, neuronal damage, and cerebral edema, promoting neuronal apoptosis and impairing neuroplasticity, ultimately exacerbating the neurologic deficit. However, neuroinflammation can also have beneficial effects by clearing cellular debris and promoting tissue repair. The role of neuroinflammation in AIS and ICH is complex and multifaceted, and further research is necessary to develop effective therapies that target this process. Intracerebral hemorrhage (ICH) will be the HS subtype addressed in this review. Neuroinflammation is a significant contributor to brain tissue damage following AIS and HS. Understanding the mechanisms and cellular players involved in neuroinflammation is essential for developing effective therapies to reduce secondary injury and improve stroke outcomes. Recent findings have provided new insights into the pathophysiology of neuroinflammation, highlighting the potential for targeting specific cytokines, chemokines, and glial cells as therapeutic strategies.
Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections

Júlia Faura,Alejandro Bustamante,Francesc Miró-Mur,Joan Montaner

DOI: https://doi.org/10.1186/s12974-021-02177-0

IF: 9.3

2021-06-06

Journal of Neuroinflammation

Abstract:Abstract Stroke produces a powerful inflammatory cascade in the brain, but also a suppression of the peripheral immune system, which is also called stroke-induced immunosuppression (SIIS). The main processes that lead to SIIS are a shift from a lymphocyte phenotype T-helper (Th) 1 to a Th2 phenotype, a decrease of the lymphocyte counts and NK cells in the blood and spleen, and an impairment of the defense mechanisms of neutrophils and monocytes. The direct clinical consequence of SIIS in stroke patients is an increased susceptibility to stroke-associated infections, which is enhanced by clinical factors like dysphagia. Among these infections, stroke-associated pneumonia (SAP) is the one that accounts for the highest impact on stroke outcome, so research is focused on its early diagnosis and prevention. Biomarkers indicating modifications in SIIS pathways could have an important role in the early prediction of SAP, but currently, there are no individual biomarkers or panels of biomarkers that are accurate enough to be translated to clinical practice. Similarly, there is still no efficient therapy to prevent the onset of SAP, and clinical trials testing prophylactic antibiotic treatment and β-blockers have failed. However, local immunomodulation could open up a new research opportunity to find a preventive therapy for SAP. Recent studies have focused on the pulmonary immune changes that could be caused by stroke similarly to other acquired brain injuries. Some of the traits observed in animal models of stroke include lung edema and inflammation, as well as inflammation of the bronchoalveolar lavage fluid.

immunology,neurosciences
Immunodepression, Infections, and Functional Outcome in Ischemic Stroke.

Willeke F. Westendorp,Claudia Dames,Paul J. Nederkoorn,Andreas Meisel

DOI: https://doi.org/10.1161/STROKEAHA.122.038867

IF: 10.17

2022-03-29

Stroke

Abstract:Stroke remains one of the main causes of mortality and morbidity worldwide. Immediately after stroke, a neuroinflammatory process starts in the brain, triggering a systemic immunodepression mainly through excessive activation of the autonomous nervous system. Manifestations of immunodepression include lymphopenia but also dysfunctional innate and adaptive immune cells. The resulting impaired antibacterial defenses render patients with stroke susceptible to infections. In addition, other risk factors like stroke severity, dysphagia, impaired consciousness, mechanical ventilation, catheterization, and older age predispose stroke patients for infections. Most common infections are pneumonia and urinary tract infection, both occur in ≈10% of the patients. Especially pneumonia increases unfavorable outcome and mortality in patients with stroke; systemic effects like hypotension, fever, delay in rehabilitation are thought to play a crucial role. Experimental and clinical data suggest that systemic infections enhance autoreactive immune responses against brain antigens and thus negatively affect outcome but convincing evidence is lacking. Prevention of poststroke infections by preventive antibiotic therapy did not improve functional outcome after stroke. Immunomodulatory approaches counteracting immunodepression to prevent stroke-associated pneumonia need to account for neuroinflammation in the ischemic brain and avoid further tissue damage. Experimental studies discovered interesting targets, but these have not yet been investigated in patients with stroke. A better understanding of the pathobiology may help to develop optimized approaches of preventive antibiotic therapy or immunomodulation to effectively prevent stroke-associated pneumonia while improving long-term outcome after stroke. In this review, we aim to characterize epidemiology, risk factors, cause, diagnosis, clinical presentation, and potential treatment of poststroke immunosuppression and associated infections.

peripheral vascular disease,clinical neurology
Lipopolysaccharide exacerbates infarct size and results in worsened post-stroke behavioral outcomes

Danielle N Doll,Elizabeth B Engler-Chiurazzi,Sara E Lewis,Heng Hu,Ashley E Kerr,Xuefang Ren,James W Simpkins

DOI: https://doi.org/10.1186/s12993-015-0077-5

2015-10-13

Abstract:Background: A third of ischemic stroke cases have no traditional underlying causes such as hypertension, diabetes, atherosclerosis, obesity, or age. Moreover, thirty to forty percent of strokes occur during or acutely after an active infection and the incidence of stroke increases during flu season. We and others have shown that the combination of a minor bacterial infection mimic, 100 μg/kg of lipopolysaccharide (LPS) prior to a minor stroke-30 min transient middle cerebral artery occlusion (tMCAO)-exacerbates infarct volume in a mouse model. Thus, experimental and epidemiological data strongly suggest that infection and/or inflammation play a role in stroke occurrence and severity. However, to date, long-term outcomes of stroke during an active infection has not been studied. Methods: 3-4 month old C57Bl6/J mice were treated with saline or LPS 30 min prior to a 30 min tMCAO or sham surgery. A behavioral battery was administered to assess health status/sickness behavior, neurological deficits, motor, cognitive, and affective behaviors. Results: We show for the first time that exposure to a low dose of LPS prior to a mild stroke significantly worsens neurological deficits and sickness scores. Motor, cognitive, and affective behaviors were assessed post-stroke and while stroke significantly affected motor behavior on rotarod, LPS did not increase the motor deficits. We did not observe any effects of stroke or LPS on cognitive and affective behaviors. Conclusions: Our observations of the association between infection, stroke, and worse sickness and neurological outcomes identify (1) a clinical need to aggressively treat infections in people with risk factors for stroke and (2) the need to understand the mechanism(s) of the association between infections and stroke.
Evidence of varicella zoster virus reactivation in children with arterial ischemic stroke: Results of the VIPS II Study

Heather Jean Fullerton,the VIPS II Investigators,Nancy K Hills,Max Wintermark,Nomazulu Dlamini,Catherine Amlie-Lefond,Michael Morgan Dowling,Lori C. Jordan,Timothy J Bernard,Neil Friedman,Mitchell S. V. Elkind,Charles Grose

DOI: https://doi.org/10.1101/2024.05.26.24307958

2024-05-28

Abstract:Background: Varicella zoster virus (VZV) has been associated with focal cerebral arteriopathy (FCA) and arterial ischemic stroke (AIS) in childhood. The Vascular effects of Infection in Pediatric Stroke (VIPS) II study aimed to examine this relationship in the modern era when most children in North America and Australia receive VZV vaccination with live, attenuated virus. Methods: This 22-center prospective cohort study enrolled 205 children (28 days-18 years) with AIS (2017-2022), collected baseline [hyperacute (?72 hours; n=194) and acute (4-6 days; n=181)] and convalescent (1-6 weeks; n=74) serum samples. Sites enrolled 95 stroke-free controls with single serum samples. A virology research laboratory measured VZV IgM and IgG titers by an in-house enzyme-linked immunosorbent assay (ELISA). Baseline IgG seropositivity indicated prior exposure (vaccination/infection) and elevated IgM titers indicated recent reactivation. Results: Median (IQR) age was 11.6 (5.5-15.6) years for cases and 11.8 (6.8-15.3) years for controls. Baseline serologies indicated prior VZV exposure in 198 cases (97%) and all controls. Parents of cases reported VZV vaccination in 160 (78%) and remote chicken pox in three (1.4%). Twenty cases (9.8%) and three controls (3.1%) had serologic evidence of recent VZV reactivation (p=0.06); all had remote VZV exposure (vaccination in 19 cases and all controls) and all were asymptomatic. Recent VZV reactivation was seen in similar proportions in arteriopathic, cardioembolic, and idiopathic stroke. Of 32 cases of FCA, 4 (12.5%) had recent VZV reactivation, versus no cases of arterial dissection (n=10) or moyamoya (n=16). Conclusions: Serologic evidence of recent VZV reactivation (≈1-6 weeks prior to stroke) was present in one in 10 cases of childhood AIS, including those without arteriopathy. Clinically silent VZV reactivation may be a childhood stroke trigger despite widespread vaccination. These cases could represent waning immunity with reactivation of either vaccine virus or wild-type virus after an unrecognized secondary VZV infection.
[Inflammatory causes of stroke-Diagnostics and treatment]

Antje Schmidt-Pogoda,Frederike A Straeten,Carolin Beuker,Nils Werring,Jens Minnerup

DOI: https://doi.org/10.1007/s00115-024-01711-8

Abstract:Inflammatory causes of stroke are frequent and often pose diagnostic and therapeutic challenges due to the scarcity of randomized trials and the absence of clear guideline recommendations for many scenarios. Following the publication of the recommendations of the European Stroke Organization on primary angiitis of the central nervous system (PACNS) last year, the German Neurological Society (DGN) has issued very clear guidelines this year on the diagnostics and treatment of PACNS and updated the recommendations for systemic vasculitides; however, stroke often occurs not only as a result of primary vascular inflammation but also as a complication of another organ infection. Approximately 5% of all patients with sepsis, ca. 20% of patients with bacterial meningitis and up to 40% of patients with bacterial endocarditis suffer from a stroke as a complication. This article summarizes the key characteristics of these inflammatory causes of stroke and particularly focuses on the current recommendations for diagnostic and therapeutic management.
Stroke in the Developing Brain: Neurophysiologic Implications of Stroke Timing, Location, and Comorbid Factors

Nayo M Hill,Laura A Malone,Lisa R Sun

DOI: https://doi.org/10.1016/j.pediatrneurol.2023.08.008

Abstract:Background: Pediatric stroke, which is unique in that it represents a static insult to a developing brain, often leads to long-term neurological disability. Neuroplasticity in infants and children influences neurophysiologic recovery patterns after stroke; therefore outcomes depend on several factors including the timing and location of stroke and the presence of comorbid conditions. Methods: In this review, we discuss the unique implications of stroke occurring in the fetal, perinatal, and childhood/adolescent time periods. First, we highlight the impact of the developmental stage of the brain at the time of insult on the motor, sensory, cognitive, speech, and behavioral domains. Next, we consider the influence of location of stroke on the presence and severity of motor and nonmotor outcomes. Finally, we discuss the impact of associated conditions on long-term outcomes and risk for stroke recurrence. Results: Hemiparesis is common after stroke at any age, although the severity of impairment differs by age group. Risk of epilepsy is elevated in all age groups compared with those without stroke. Outcomes in other domains vary by age, although several studies suggest worse cognitive outcomes when stroke occurs in early childhood compared with fetal and later childhood epochs. Conditions such as congenital heart disease, sickle cell disease, and moyamoya increase the risk of stroke and leave patients differentially vulnerable to neurodevelopmental delay, stroke recurrence, silent infarcts, and cognitive impairment. Conclusions: A comprehensive understanding of the interplay of various factors is essential in guiding the clinical care of patients with pediatric stroke.
Pediatric infectious aneurysms: individual patient pooled analysis on presentation, management and outcomes

Ali Alawieh,Youssef M Zohdy,Rim El Annan,Jad H Assi,Laurie Dimisko,Jonathan A Grossberg,C Michael Cawley,Katherine Chandler,Joshua J Chern,Michael S Sawvel,Barunashish Brahma,Tomas Garzon-Muvdi,Gustavo Pradilla,Daniel Barrow,Andrew Reisner,Brian M Howard

DOI: https://doi.org/10.1136/jnis-2023-021195

IF: 4.8

2024-01-03

Journal of NeuroInterventional Surgery

Abstract:Background Infectious intracranial aneurysms (IIAs) are a rare sequel of systemic infection and occur most commonly in patients with infective endocarditis (IE). Despite the increasing use of non-invasive screening angiography in patients with IE, the incidence remains low, yielding limited data on the management of IIAs in pediatric populations. We performed a pooled analysis of all published series of pediatric patients with IIAs to study the disease landscape including presentation, management, and outcomes. Methods Data included in this study were pooled from published literature on IIAs between 1960 and 2023. Abstracts were selected for full review to include only manuscripts reporting at least one case of pediatric IIA (age 0–18 years). Results A total of 145 pediatric patients with 178 IIAs were included. Patients presented with rupture in 68% of cases, of which 36% had intraparenchymal hemorrhage and 39% had subarachnoid hemorrhage. Using multivariate logistic regression, independent predictors of rupture were posterior location (aOR 10, P=0.041) and history of IE (aOR 7.2, P=0.001). Primary medical management was successful in 82% of cases with unruptured aneurysms while, in those with ruptured IIAs, medical management was successful in 26% of cases. The 90-day mortality rate was 28%. Using multivariate logistic regression, ruptured IIAs (aOR 5.4, P<0.01) and failure of medical management (aOR 11.1, P<0.05) were independent predictors of 90-day mortality. Conclusion Pediatric IIAs remain a rare complication of systemic or localized CNS infection in the pediatric population. Medical management of unruptured aneurysms is highly successful, while ruptured aneurysms have a remarkably high rate of failure of medical management and should be treated by early surgical or endovascular intervention when feasible.

surgery,neuroimaging

Suitability of date palm (Phoenix dactyliferia) branches for particleboard production

Immune-Neurovascular Interactions in Experimental Perinatal and Childhood Arterial Ischemic Stroke

Infection and Pediatric Arterial Ischemic Stroke Presumably Related to Focal Cerebral Arteriopathy: Data From the COVID-19 Pandemic

Be aware of childhood stroke: Proceedings from EPNS Webinar

Abstract 112: Assessing the Impact of the COVID-19 Pandemic on Childhood Arterial Ischemic Stroke: An Unanticipated Natural Experiment

Osteodystrophic diseases of sheep. II. Rickets in young sheep.

Energetic aspects of CO2 uptake in Thiobacillus neapolitanus

Inflammation and Infections as Risk Factors for Ischemic Stroke

New Directions in Infection-Associated Ischemic Stroke

The incidence of pediatric ischemic stroke: A systematic review and meta-analysis

Diffuse embryoma with intratubular germ‐cell neoplasia

Immune Pathways in Etiology, Acute Phase, and Chronic Sequelae of Ischemic Stroke

Factors Associated with Pathway-Concordant Neuroimaging for Pediatric Ischemic Stroke

Neuroinflammation in Acute Ischemic and Hemorrhagic Stroke

Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections

Immunodepression, Infections, and Functional Outcome in Ischemic Stroke.

Lipopolysaccharide exacerbates infarct size and results in worsened post-stroke behavioral outcomes

Evidence of varicella zoster virus reactivation in children with arterial ischemic stroke: Results of the VIPS II Study

[Inflammatory causes of stroke-Diagnostics and treatment]

Stroke in the Developing Brain: Neurophysiologic Implications of Stroke Timing, Location, and Comorbid Factors

Pediatric infectious aneurysms: individual patient pooled analysis on presentation, management and outcomes